Adalimumab (up to 9 months exposure) ( DrugBank: Adalimumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

46. 悪性関節リウマチ

臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00233558 (ClinicalTrials.gov)	June 2005	13/9/2005	Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoi ...	Multicentre, Randomised, Open Label Study Comparing a Scheduled Steroid Reduction Strategy” Versus a ...	Rheumatoid Arthritis	Drug: adalimumab (up to 9 months exposure);Drug: methotrexate	Abbott	NULL	Terminated	18 Years	N/A	Both	160	Phase 4	United States

First Previous1Next Last